Progress in the development of human parainfluenza virus vaccines
10.3760/cma.j.cn112866-20230731-00011
- VernacularTitle:人副流感病毒疫苗研究进展
- Author:
Huanru WANG
1
;
Fanghao FANG
;
Xue ZHAO
;
Wei WANG
;
Min CHEN
;
Zheng TENG
Author Information
1. 上海市疾病预防控制中心病原所，上海 200336
- Keywords:
Human parainfluenza virus;
Vaccine;
Respiratory infection;
Prevention
- From:
Chinese Journal of Experimental and Clinical Virology
2023;37(5):558-563
- CountryChina
- Language:Chinese
-
Abstract:
Human parainfluenza virus (HPIV) is important respiratory pathogen that could cause bronchitis and pneumonia in infants, young children and other immunocompromised populations. At present, there are no vaccines or drugs approved for specific prevention and treatment of HPIV infection. In this review we introduce the development of HPIV vaccines from five categories including inactivated vaccine, live attenuated vaccine, subunit vaccine, mRNA vaccine and combined vaccine.
